Amanote Research

Amanote Research

    RegisterSign In

The Specific Serotonin Reuptake Inhibitors Sertraline and Fluoxetine Promote Tumor Growth in a Mouse Xenograft Model of Cholangiocarcinoma

Matters
doi 10.19185/matters.201706000003
Full Text
Open PDF
Abstract

Available in full text

Date

September 14, 2017

Authors
Matthew McMillinJenny SmithHope ShinGabriel FramptonAnca PetrescuJessica KainAmy WyattStephanie GrantSharon DeMorrow
Publisher

Sciencematters


Related search

Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors and Migraine: Should Cochrane Close the Door?

Journal of Biomedical Science and Engineering
2018English

Selective Serotonin Reuptake Inhibitors.

BMJ
1992English

Serotonin Noradrenaline Reuptake Inhibitors (SNRIs)

2012English

Selective Serotonin Reuptake Inhibitors Induced Serotonin Syndrome –A Case Report

International Journal of Hospital Pharmacy
2017English

147 Ruxolitinib Reverses Accelerated Tumor Growth of RDEB-cSCCs in a Xenograft Mouse Model

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

4 Serotonin and Reuptake Inhibitors of Biogenic Amines

2019English

Selective Serotonin Reuptake Inhibitors and Operative Bleeding Risk

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2016English

Selective Serotonin Reuptake Inhibitors for Fibromyalgia Syndrome

Sao Paulo Medical Journal
Medicine
2015English

Selective Serotonin Reuptake Inhibitors (SSRIs) for Stroke

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy